Skip header and navigation

Narrow By

32 records – page 2 of 2.

Quitting smoking to lower your risk of cervical cancer

https://libcat.nshealth.ca/en/permalink/chpams37302
Nova Scotia Health Authority. Department of Obstetrics and Gynecology. Division of Gynaecologic Oncology. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2167
Available Online
View Pamphlet
Cervical cancer is cancer that starts in the cervix. The cervix is the lower part of the uterus (womb) that opens at the top of the vagina. This pamphlet explains how smoking increases your chance of getting cervical cancer, other reasons to quit smoking, what nicotine replacement therapy (NRT) is and how much it will cost, why e-cigarettes are not recommended, medications that are available to help you quit smoking, and other options to quit smoking. Tips for quitting smoking and a list of res…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Department of Obstetrics and Gynecology. Division of Gynaecologic Oncology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Smoking Cessation
Uterine Cervical Neoplasms - prevention & control
Subjects (LCSH)
Smoking cessation
Cervix uteri--Cancer--Prevention
Specialty
Gynecology
Abstract
Cervical cancer is cancer that starts in the cervix. The cervix is the lower part of the uterus (womb) that opens at the top of the vagina. This pamphlet explains how smoking increases your chance of getting cervical cancer, other reasons to quit smoking, what nicotine replacement therapy (NRT) is and how much it will cost, why e-cigarettes are not recommended, medications that are available to help you quit smoking, and other options to quit smoking. Tips for quitting smoking and a list of resources are also provided.
Responsibility
Prepared by: Department of Obstetrics and Gynecology: Division of Gynaecologic Oncology
Pamphlet Number
2167
Less detail

Medicine coverage

https://libcat.nshealth.ca/en/permalink/chpams37352
Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2023.
Pamphlet Number
4028
Available Online
View Pamphlet
There are two types of medications that you may need during your cancer care: drugs to treat your cancer and drugs to support your cancer care and deal with side effects. You may be worried about how much you will have to pay for cancer medications. This pamphlet explains what support is available if you don't have an insurance plan, how to find out if your insurance plan or Nova Scotia Pharmacare plan will cover your medications, what you can do if your medications are not covered, and whether…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Alternate Title
Medication coverage
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Health Care Costs
Insurance, Health
Insurance, Pharmaceutical Services
Subjects (LCSH)
Health insurance
Medical care, Cost of
Pharmaceutical services insurance
Specialty
Cancer Care
Abstract
There are two types of medications that you may need during your cancer care: drugs to treat your cancer and drugs to support your cancer care and deal with side effects. You may be worried about how much you will have to pay for cancer medications. This pamphlet explains what support is available if you don't have an insurance plan, how to find out if your insurance plan or Nova Scotia Pharmacare plan will cover your medications, what you can do if your medications are not covered, and whether the Canadian Cancer Society helps with drug costs. Contact information for more support is included.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4028
Less detail

High sodium foods to limit or avoid

https://libcat.nshealth.ca/en/permalink/chpams37550
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0550
Available Online
View Pamphlet
Eating too much sodium (salt) can lead to high blood pressure, kidney disease, and liver and heart problems. If you have heart, kidney, or liver disease, following a low sodium meal plan can help you manage your condition and feel better. This pamphlet explains how to control sodium intake. Foods to limit or avoid are listed. Information about portion size, how to read a nutrition label, and how to plan meals is included. A list of resources is provided. How to locate nutrition counselling in y…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Heart Diseases - diet therapy
Sodium restricted diet
Subjects (LCSH)
Heart--Diseases--Diet therapy
Salt-free diet
Specialty
Food and Nutrition
Abstract
Eating too much sodium (salt) can lead to high blood pressure, kidney disease, and liver and heart problems. If you have heart, kidney, or liver disease, following a low sodium meal plan can help you manage your condition and feel better. This pamphlet explains how to control sodium intake. Foods to limit or avoid are listed. Information about portion size, how to read a nutrition label, and how to plan meals is included. A list of resources is provided. How to locate nutrition counselling in your area is included.
Notes
Previous title: High Sodium Foods to Avoid
Responsibility
Nutrition and Food Services
Pamphlet Number
0550
Less detail

Restraint considerations for patients and families

https://libcat.nshealth.ca/en/permalink/chpams37624
Nova Scotia Health Authority. Interprofessional Practice and Learning. Least Restraint Working Group. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0599
Available Online
View Pamphlet
A restraint is anything that limits a person’s movement. Restraints can help to keep you from getting hurt or hurting others, including your caregivers. Nova Scotia Health’s goal is to promote the health and well-being of all of our patients. We try to help you keep as much comfort, independence, and quality of life as possible. Nova Scotia Health policy states restraints are to be used only as a last resort. This pamphlet explains why and when restraints are used, ways you and your support per…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Interprofessional Practice and Learning. Least Restraint Working Group
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Geriatrics
Immobilization
Subjects (LCSH)
Geriatrics
Restraint of patients
Specialty
Geriatrics
Abstract
A restraint is anything that limits a person’s movement. Restraints can help to keep you from getting hurt or hurting others, including your caregivers. Nova Scotia Health’s goal is to promote the health and well-being of all of our patients. We try to help you keep as much comfort, independence, and quality of life as possible. Nova Scotia Health policy states restraints are to be used only as a last resort. This pamphlet explains why and when restraints are used, ways you and your support person(s) can help without using a restraint, and what to do If you are not happy with how you or your loved one is being restrained.
Responsibility
Prepared by: IPPL Least Restraint Working Group
Pamphlet Number
0599
Less detail

Can I have a diagnostic imaging test while I am pregnant?

https://libcat.nshealth.ca/en/permalink/chpams38149
Nova Scotia Health Authority. Eastern Zone. Diagnostic Imaging QI Committee. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2317
Available Online
View Pamphlet
Diagnostic imaging tests take pictures of the inside of your body. These tests include X-rays, computed tomography (CT) scans, nuclear medicine scans, ultrasounds, and magnetic resonance imaging (MRI). Topics include: why you may need to have a test, whether you can have a different test that does not use radiation, how much radiation is safe during pregnancy, who will do your test, asking questions, what to do if you refuse to have the test, and what to do if you find out you are pregnant afte…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Eastern Zone. Diagnostic Imaging QI Committee
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Diagnostic Imaging - adverse effects
Pregnancy--radiation effects
Subjects (LCSH)
Pregnant women--Radiography
Specialty
Diagnostic Imaging
Abstract
Diagnostic imaging tests take pictures of the inside of your body. These tests include X-rays, computed tomography (CT) scans, nuclear medicine scans, ultrasounds, and magnetic resonance imaging (MRI). Topics include: why you may need to have a test, whether you can have a different test that does not use radiation, how much radiation is safe during pregnancy, who will do your test, asking questions, what to do if you refuse to have the test, and what to do if you find out you are pregnant after a test.
Responsibility
Prepared by: Diagnostic Imaging QI Committee, Eastern Zone
Pamphlet Number
2317
Less detail

Getting enough iron during pregnancy

https://libcat.nshealth.ca/en/permalink/chpams38168
Nova Scotia Health Authority. South Shore Regional Hospital. OBS Clinic. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2330
Available Online
View Pamphlet
Iron helps your blood carry oxygen through your body. When your iron levels are too low, you can develop a condition called iron deficiency anemia. This can lead to serious health issues. A person who is pregnant needs more iron to support the growth of their baby. During pregnancy, you need about one third (1/3) more iron. This pamphlet explains how much iron you need each day, how you can make sure you get enough iron, and how you will know if you are getting enough iron. Space is included fo…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. South Shore Regional Hospital. OBS Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Iron, Dietary
Pregnancy
Subjects (LCSH)
Iron in human nutrition
Pregnancy
Specialty
Gynecology
Abstract
Iron helps your blood carry oxygen through your body. When your iron levels are too low, you can develop a condition called iron deficiency anemia. This can lead to serious health issues. A person who is pregnant needs more iron to support the growth of their baby. During pregnancy, you need about one third (1/3) more iron. This pamphlet explains how much iron you need each day, how you can make sure you get enough iron, and how you will know if you are getting enough iron. Space is included for your health care team to record your hemoglobin and ferritin levels. Instructions on how to take elemental iron are given.
Responsibility
Prepared by: OBS Clinic, South Shore Regional Hospital
Pamphlet Number
2330
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1466
Less detail

Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1465
Available Online
View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Cinacalcet
Renal Insufficiency, Chronic - drug therapy
Hyperparathyroidism, Secondary - drug therapy
Subjects (LCSH)
Chronic renal failure
Hyperparathyroidism
Kidneys--Diseases--Treatment
Abstract
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
Notes
Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
Responsibility
Prepared by: Renal Program
Pamphlet Number
1465
Less detail

Sevelamer (Renagel) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1464
Available Online
View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sevelamer
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Chronic renal failure
Kidneys--Diseases--Treatment
Abstract
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
Notes
Previous title: Renagel (Sevelamer) and Hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1464
Less detail

Ustekinumab (Stelara) therapy

https://libcat.nshealth.ca/en/permalink/chpams35722
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1695
Available Online
View Pamphlet
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taki…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Ustekinumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Crohn's disease
Ulcerative colitis
Specialty
Medications
Abstract
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taking ustekinumab and while you are taking it are listed. Possible side effects, information about pregnancy and breast/chest feeding, and other important things to know are included.
Notes
Previous title: Ustekinumab (Stelara) therapy for Crohn's disease
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1695
Less detail

Cannabinoïdes pour le traitement de la douleur

https://libcat.nshealth.ca/en/permalink/chpams35847
Nova Scotia Health Authority. Pain Management Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1792
Available Online
View Pamphlet
Les cannabinoïdes sont un groupe de médicaments parfois appelés « analgésiques à la marijuana » (antidouleurs) ou « cannabioïdes synthétiques » (artificiels). Ce dépliant explique pourquoi on vous a prescrit un cannabinoïde, la quantité et la façon de prendre ce médicament, les effets secondaires et la manière de rester en sécurité lorsque vous prenez ce médicament. Vous y trouverez également de l'information sur la conservation de ce médicament et sur ce qu'il faut faire en cas d'oubli d'une d…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pain Management Unit
Alternate Title
Cannabinoids for managing pain
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cannabinoids
Analgesics
Pain Management
Subjects (LCSH)
Cannabinoids
Analgesics
Pain--Treatment
Abstract
Les cannabinoïdes sont un groupe de médicaments parfois appelés « analgésiques à la marijuana » (antidouleurs) ou « cannabioïdes synthétiques » (artificiels). Ce dépliant explique pourquoi on vous a prescrit un cannabinoïde, la quantité et la façon de prendre ce médicament, les effets secondaires et la manière de rester en sécurité lorsque vous prenez ce médicament. Vous y trouverez également de l'information sur la conservation de ce médicament et sur ce qu'il faut faire en cas d'oubli d'une dose.
This pamphlet is a French translation of "Cannabinoid Analgesics for Pain Management" pamphlet 1350. Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included.
Responsibility
Prepared by: Pain Management Unit
Pamphlet Number
1792
Less detail

Open thoracotomy pulmonary resection

https://libcat.nshealth.ca/en/permalink/chpams35596
Nova Scotia Health Authority. QEII. Thoracic Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1611
Available Online
View Pamphlet
This guide is for patients that are being admitted to the Victoria General Hospital for open thoracotomy pulmonary resection surgery for lung cancer treatment. Your surgeon will make a surgical cut between two ribs. The cut will go from the front of your chest wall to your back, passing just underneath your armpit. These ribs will be separated. Your lung on this side will be deflated so that air will not move in and out of it during surgery. Your surgeon may not know how much of your lung needs…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Thoracic Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (23 p.) : digital, PDF file
Subjects (MeSH)
Thoracotomy
Lung - surgery
Subjects (LCSH)
Lungs--Surgery
Lungs--Cancer--Surgery
Abstract
This guide is for patients that are being admitted to the Victoria General Hospital for open thoracotomy pulmonary resection surgery for lung cancer treatment. Your surgeon will make a surgical cut between two ribs. The cut will go from the front of your chest wall to your back, passing just underneath your armpit. These ribs will be separated. Your lung on this side will be deflated so that air will not move in and out of it during surgery. Your surgeon may not know how much of your lung needs to be removed until your chest is open and the lung can be seen. After surgery, one or more drainage tubes (chest tubes) will be placed into your chest area to drain out fluids that build up. After the surgery on your lung, your surgeon will close the ribs, muscles, and skin with stitches. The health care team has put together a guide called a Clinical Pathway so you will know what will happen to you before surgery and on a day-to-day basis after surgery. A Clinical Pathway is a general guideline about your care.
Responsibility
Prepared by: Thoracic Clinic Health Care Staff
Pamphlet Number
1611
Less detail

32 records – page 2 of 2.